Genetic studies in rat models: Insights into cardiovascular disease

Current Opinion in Lipidology

Volumn 16, Issue 2, 2005, Pages 179-191

  Herrera, Victoria L M ^a   Ruiz Opazo, Nelson ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Complex cardiovascular disease; Hypertension; QTLs; Rat genetic studies; Transgenic rat

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CORONARY ARTERY DISEASE; DISEASE PREDISPOSITION; ESSENTIAL HYPERTENSION; EXPERIMENTAL MODEL; FEMALE; GENE CLUSTER; GENETIC ANALYSIS; GENETIC HETEROGENEITY; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HEART VENTRICLE HYPERTROPHY; HYPERLIPIDEMIA; HYPERTENSION; KIDNEY DISEASE; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; QUANTITATIVE TRAIT LOCUS; RAT; RAT STRAIN; REVIEW; RISK FACTOR; SEX DIFFERENCE; STROKE; TRANSGENIC ANIMAL; TRANSGENIC RAT;

EID: 17144399923     PISSN: 09579672     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mol.0000162323.77666.5e     Document Type: Review

References (46)

1. Kato N, Nabika T, Liang YQ, et al. Isolation of a chromosome 1 region affecting blood pressure and vascular disease traits in the stroke-prone rat model. Hypertension 2003; 42:1191-1197. This presents an analysis of the relationship of hypertension and propensity to stroke.
2. Moreno C, Dumas P, Kaldunski MU, et al. Genomic map of cardiovascular phenotypes of hypertension in female Dahl S rats. Physiol Genomics 2003; 15:243-257. This seminal paper reports extensive female-specific linkage analysis of 236 neuroendocrine, renal and cardiovascular traits related to blood pressure in 99 F2 (BNxSS) intercross rats.
3. Siegel AK, Planert M, Rademacher S, et al. Genetic loci contribute to the progression of vascular and cardiac hypertrophy in salt-sensitive spontaneous hypertension. Arterioscler Thromb Vasc Biol 2003; 23:1211-1217. This QTL analysis for salt-sensitive hypertension associated cardiac and vascular (aortic) hypertrophy in rat model investigated susceptibility to end-organ damage in human salt-sensitive hypertension.
4. Bilusic M, Bataillard A, Tschannen MR, et al. Mapping the genetic determinants of hypertension, metabolic diseases, and related phenotypes in the Lyon hypertensive rat Hypertension 2004; 44:695-701. This was a genetic study with comprehensive characterization of F2-intercross phenotype on regular rat chow using the Lyon hypertensive rat model.
5. Ueno T, Tremblay J, Kunes J, et al. Gender-specific genetic determinants of blood pressure and organ weight: pharmacogenetic approach. Physiol Res 2003; 52:689-700.
6. Lee SJ, Liu J, Qi N, et al. Use of a panel of congenic strains to evaluate differentially expressed genes as candidate genes for blood pressure quantitative trait loci. Hypertens Res 2003; 26:75-87.
7. Yagil C, Hubner N, Kreutz R, et al. Congenic strains confirm the presence of salt-sensitivity QTLs on chromosome 1 in the Sabra rat model of hypertension. Physiol Genomics 2003; 12:85-95.
8. Meng J, Garrett MR, Dene H, Rapp JP. Localization of a blood pressure QTL to a 2.4 cM interval on rat chromosome 9 using congenic strains. Genomics 2003; 81:210-220.
9. Joe B, Garrett MR, Dene H, Rapp JP. Substitution mapping of a blood pressure quantitative trait locus to a 2.73 Mb region on rat chromosome 1. J Hypertension 2003; 21:2077-2084. This demonstrates the advantage and limits of congenic approaches in the elucidation of susceptibility genes.
10. Garrett MR, Rapp JP. Defining the blood pressure QTL on chromosome 7 in Dahl rats by a 177-kb congenic segment containing Cyp11b1. Mammalian Genome 2003; 14:268-273.
11. Pravenec M, Kren V, Krenova D, et al. Genetic isolation of quantitative trait loci for blood pressure development and renal mass on chromosome 5 in the spontaneously hypertensive rat. Physiol Res 2003; 52:285-289.
12. Palijan A, Lambert R, Dutil J, et al. Comprehensive congenic coverage revealing multiple blood pressure quantitative trait loci on Dahl rat chromosome 10. Hypertension 2003; 42:515-522. This demonstrates the QTL-cluster concept for blood pressure susceptibility.
13. Monti J, Zimdahl H, Schulz H, et al. The role of Wnk4 in polygenic hypertension: a candidate gene analysis on rat chromosome 10. Hypertension 2003; 41:938-942.
14. Kaneko Y, Herrera VL, Didishvili T, Ruiz-Opazo N. Gender-specific effects of dual ET-1/AngII receptor (Dear) variants in Dahl salt-sensitive/resistance hypertension rat model. Physiol Genomics 2004; (Epub ahead of print). This provides experimental evidence for sex-specific susceptibility in salt-sensitive hypertension.
15. Lander E, Kruglyak L. Genetic dissection of complex traits: guidelines for interpreting and reporting linkage results. Nat Genet 1995; 11:241-247.
16. Herrera VLM, Traverse S, Lopez LV, Ruiz-Opazo N. X-linked locus associated with hypertensive renal disease susceptibility in Dahl rats. J Hypertens 2003; 21:67-71.
17. Gigante B, Rubattu S, Stanzione R, et al. Contribution of genetic factors to renal lesions in the stroke-prone spontaneously hypertensive rat. Hypertension 2003; 42:702-706.
18. Siegel AK, Kossmehl P, Planert M, et al. Genetic linkage of albuminuria and renal injury in Dahl salt-sensitive rats on a high-salt diet: comparison of spontaneously hypertensive rats. Physiol Genomics 2004; 18:218-225.
19. Poyan Mehr A, Siegel AK, Kossmehl P, et al. Early onset albuminuria in Dahl rats is a polygenetic trait that is independent from salt loading. Physiol Genomics 2003; 14:209-216.
20. Herrera VL, Didishvili T, Lopez LV, et al. Genome-wide scan identifies novel QTLs for cholesterol and LDL levels in F2[Dahl RxS]-intercross rats. Circ Res 2004; 94:446-452. An F2 total genome search identified new QTLs for total cholesterol and LDL with syngeneic regions in humans.
21. Ueno T, Tremblay J, Kunes J, et al. Rat model of familial combined hyperlipidemia as a result of comparative mapping. Physiol Genomics 2004; 17:38-47.
22. Watanabe TK, Okuno S, Yamasaki Y, et al. A <1.7 cM interval is responsible for Dmo1 obesity phenotypes in OLETF rats. Clin Exp Pharmacol Physiol 2004; 31:110-112.
23. Ogino T, Moralejo DH, Kose H, et al. Serum leptin concentration is linked to chromosomes 2 and 6 in the OLETF rat, an animal model of type 2 diabetes with mild obesity. Mamm Genome 2003; 14:839-844.
24. Masuyama T, Fuse M, Yokoi N, et al. Genetic analysis for diabetes in a new rat model of nonobese type 2 diabetes, Spontaneously Diabetic Torii rat. Biochem Biophys Res Commun 2003; 304:196-206. The experimental design simulates human type 2 diabetes: 20-week-old time point associated with 38-week onset of type 2 diabetes. Gene interactions were investigated. QTLs for glucose intolerance found on chromosomes 1, 2, and X with synergistic interactions among these QTLs.
25. Wallis RH, Wallace KJ, Collins SC, et al. Enhanced insulin secretion and cholesterol metabolism in congenic strains of the spontaneously diabetic (Type 2) Goto Kakizaki rat are controlled by independent genetic loci in rat chromosome 8. Diabetologia 2004; 6:1096-1106.
26. Muramatsu Y, Taniguchi Y, Kose H, et al. Capn 10, a candidate gene responsible for type 2 diabetes mellitus in the OLETF rat. IUBMB Life 2003; 55:533-537.
27. Butler AE, Jang J, Gurlo T, et al. Diabetes due to a progressive defect in beta-cell mass in rats transgenic for human islet amyloid polypeptide (HIP rat): a new model for type 2 diabetes. Diabetes 2004; 53:1509-1516. This is a strategic new model for type 2 diabetes with onset between 5 and 10 months of age developed via transgenesis. The value of transgenic rat experiments is seen in the causal role analysis of human islet amyloid polypeptide.
28. Herrera VL, Tsikoudakis A, Didishvili T, et al. Analysis of gender-specific atherosclerosis susceptibility in transgenic [hCETP]25(DS) rat model. Atherosclerosis 2004; 177:9-18. This transgenic study unequivocally demonstrated sex-specific susceptibility to atherogenic paradigms. Vascular susceptibility as a paradigm in coronary artery disease pathogenesis was shown.
29. Herrera VL, Shen L, Lopez LV, et al. Chlamydia pneumoniae accelerates coronary artery disease progression in transgenic hyperlipidemia-genetic hypertension rat model. Mol Med 2003; 9:135-142.
30. Pravenec M, Landa V, Zidek V, et al. Transgenic expression of CD36 in the spontaneously hypertensive rat is associated with amelioration of metabolic disturbances but has no effect on hypertension. Physiol Res 2003; 52:681-688. Transgenic rat model in inbred SHRs showing causal role of CD36 variant in defective fatty acid metabolism and insulin resistance. The data eliminate a causal role of CD38 in hypertension.
31. Tschope C, Walther T, Koniger J, et al. Prevention of cardiac fibrosis and left ventricular dysfunction in diabetic cardiomyopathy in rats by transgenic expression of the human tissue kallikrein gene. FASEB J 2004; 18:828-835.
32. Chen Y, Escoubet B, Prunier F, et al. Constitutive cardiac overexpression of sarcoplasmic/endoplasmic reticulum Ca2+ATPase delays myocardial failure after myocardial infarction in rats at a cost of increased acute arrhythmias. Circulation 2004; 109:1898-1903.
33. Muller OJ, Lange M, Rattunde H, et al. Transgenic rat hearts overexpressing SERCA2a show improved contractility under baseline conditions and pressure overload. Cardiovasc Res 2003; 59:380-389.
34. Wernicke D, Thiel C, Duja-Isac CM, et al. Alpha-tropomyosin mutations Asp(175)Asn and Glu(180)Gly affect cardiac function in transgenic rats in different ways. Am J Physiol Regul Integr Comp Physiol 2004; 287:R685-R695.
35. Braudeau C, Bouchet D, Toquet C, et al. Generation of heme oxygenase-1 transgenic rats. Exp Biol Med 2003; 228:466-471.
36. Rapp JP. Genetic analysis of inherited hypertension in the rat. Physiol Rev 2000; 80:135-168.
37. Frankel WN, Schork NJ. Who's afraid of epistasis? Nat Genet 1996; 14:371-373.
38. Cowley AW, Roman RJ, Jacob HJ. Application of chromosomal substitution techniques in gene-function discovery. J Physiol 2003; 554:46-55. This is an analysis of consomics as an approach in gene-function and gene-disease analyses.
39. Michalkiewicz M, Michalkiewicz T, Ettinger RA, et al. Transgenic rescue demonstrates involvement of the Ian5 gene in T cell development in the rat. Physiol Genomics 2004; 19:228-232. This presents an aggressive use of transgenic modeling to demonstrate a culprit gene.
40. Kwitec AE, Gullings-Handley J, Yu J, et al. High-density rat radiation hybrid maps containing over 24,0000 SSLPs, genes, and ESTS provide a direct link to the rat genome sequence. Genome Research 2004; 14:750-757.
41. James JF, Hewett TE, Robbins J. Cardiac physiology in transgenic mice. Circ Res 1998; 82:407-415.
42. Vetter R, Rehfeld U, Reissfelder C, et al. Transgenic overexpression of the sarcoplasmic reticulum Ca2+ATPase improves reticular Ca2+ handling in normal and diabetic rat hearts. FASEB J 2002; 16:1657-1659.
43. Mashimo T, Nabika T, Matsumoto C, et al. Aging and salt-loading modulate blood pressure QTLs in rats. Am J Hypertens 1999; 12(11 Pt 1):1098-1104.
44. Yagil Y, Yagil C. Problems with linkage analysis and QTL detection in hypertension. J Hypertension 2003; 21:247-249. This is an editorial comment on the complexity of analyzing hypertension genetics. It presents key perspectives.
45. Yagil Y, Yagil C. Congenics in the pathway from quantitative trait loci detection to gene identification: is that the way to go? J Hypertension 2003; 21:2009-2011. This editorial comment on congenic approaches to analyzing hypertension genetics presents key perspectives.
46. Gibbs RA, Weinstock GM, Metzker ML, et al. Rat Genome Sequencing Project Consortium. Genome sequence of the Brown Norway rat yields insights into mammalian evolution. Nature 2004; 428:493-521. This reports on the completion of the brown Norway rat genome sequence, a key resource for the detection of non-conservative allele variants of candidate genes for complex cardiovascular disease.